Sara Almasian, NP
Nurse Practitioner · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 4
- Since medical school
- 9 years
- Graduated 2017
Offices
4 locations · University of California San Francisco · 1,780 clinicians in this group
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Sara Almasian’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$28,623
Medicare paid this office $28,623 for 233 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 84 | $8,602 | $66 |
| Return visit (30+ min) | 50 | $3,620 | $68 |
| Long return visit (40+ min) | 24 | $3,092 | $97 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,778 | $132 |
| Long return visit (40+ min) | 17 | $1,881 | $99 |
See all 10 services
| Return visit (30+ min) | 84 | $8,602 | $66 |
| Return visit (30+ min) | 50 | $3,620 | $68 |
| Long return visit (40+ min) | 24 | $3,092 | $97 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,778 | $132 |
| Long return visit (40+ min) | 17 | $1,881 | $99 |
| Short return visit (20+ min) | 40 | $1,827 | $44 |
| Short return visit (20+ min) | 35 | $1,604 | $46 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $915 | $42 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 40 | $716 | $12 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 35 | $502 | $13 |
Who their Medicare patients are
233 Original Medicare patients in 2024. Average age 72 · Under 65 10% · 85 and older 7% · Women 91% · Also on Medicaid 30% · Health risk score 1.19. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 58% · Depression 30% · Chronic kidney disease 22% · Cancer 20% · Diabetes 19% · Coronary heart disease 16% · COPD 13% · Atrial fibrillation 10% · Heart failure 9% · Stroke 8% · Dementia 5%.
The office billed $217,871, Medicare allowed $38,422 and paid $28,623; for 512 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 233 | 512 | 72 | 1.19 | $217,871 | $28,623 |
| 2023 | 172 | 231 | 72 | 1.05 | $112,411 | $15,131 |
| 2022 | 75 | 108 | 76 | 1.12 | $33,466 | $8,359 |
| 2021 | 99 | 161 | 75 | 0.99 | $41,515 | $12,280 |
| 2020 | 133 | 179 | 75 | 1.08 | $38,016 | $9,407 |
| 2019 | 200 | 274 | 77 | 1.18 | $59,252 | $14,552 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 53 | $3,793 | $64 |
| Long return visit (40+ min) | 22 | $3,224 | $107 |
| Short return visit (20+ min) | 41 | $1,842 | $44 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $663 | $47 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $460 | $38 |
2022: 3 services
| Return visit (30+ min) | 34 | $3,035 | $84 |
| Long return visit (40+ min) | 12 | $1,513 | $116 |
| Short return visit (20+ min) | 13 | $812 | $62 |
2021: 3 services
| Return visit (30+ min) | 45 | $4,673 | $90 |
| Long return visit (40+ min) | 14 | $1,998 | $133 |
| Short return visit (20+ min) | 24 | $1,622 | $65 |
2020: 3 services
| Return visit (30+ min) | 49 | $3,505 | $69 |
| Short return visit (20+ min) | 61 | $2,945 | $48 |
| Automated urinalysis test | 11 | $25 | $2 |
2019: 3 services
| Short return visit (20+ min) | 150 | $8,487 | $51 |
| Return visit (30+ min) | 52 | $4,725 | $84 |
| Automated urinalysis test | 23 | $56 | $2 |
Medicaid work
$28,196 in 2018
Medicaid paid $28,196 for 519 billed services this clinician did in 2018, up to 49 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 142 | $26,614 |
| Short return visit (20+ min) | 272 | $1,426 |
| Acupuncture, initial 15 minutes | 13 | $78 |
| Acupuncture, each additional 15 minutes | 13 | $78 |
| Short return visit | 58 | $0 |
| EMERGENCY DEPT VISIT LOW MDM | 21 | $0 |
| 2018 | 519 | 6 | 49 | $28,196 |
Drugs they prescribed that Part D paid
$137,653
Pharmacies billed $137,653 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (49 of 1,534) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 22% of their opioid prescriptions.
1,319 generic and fewer than 11 brand-name prescriptions · $137,653 in drug cost · 91 antibiotic prescriptions to 59 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 16 | $14,487 | $905 |
| Synthroid | 18 | $2,029 | $113 |
| Paxlovid | 12 | $1,429 | $119 |
| Albuterol Sulfate Hfa | 20 | $824 | $41 |
| Gabapentin | 38 | $635 | $17 |
See all 40 drugs
| Eliquis | 16 | $14,487 | $905 |
| Synthroid | 18 | $2,029 | $113 |
| Paxlovid | 12 | $1,429 | $119 |
| Albuterol Sulfate Hfa | 20 | $824 | $41 |
| Gabapentin | 38 | $635 | $17 |
| Omeprazole | 45 | $564 | $13 |
| Hydrocodone-Acetaminophen | 23 | $562 | $24 |
| Atorvastatin | 81 | $535 | $7 |
| Levothyroxine | 43 | $500 | $12 |
| Diclofenac | 11 | $468 | $43 |
| Losartan | 53 | $431 | $8 |
| Metoprolol | 41 | $402 | $10 |
| Trazodone | 24 | $377 | $16 |
| Nortriptyline | 17 | $376 | $22 |
| Baclofen | 18 | $332 | $18 |
| Nitrofurantoin Mono-Macro | 29 | $305 | $11 |
| Amlodipine Besylate | 58 | $286 | $5 |
| Oxycodone | 12 | $262 | $22 |
| Famotidine | 24 | $242 | $10 |
| Rosuvastatin | 20 | $234 | $12 |
| Lorazepam | 32 | $233 | $7 |
| Pantoprazole | 21 | $227 | $11 |
| Triamcinolone Acetonide | 15 | $221 | $15 |
| Lisinopril | 42 | $213 | $5 |
| Montelukast | 12 | $171 | $14 |
| Metformin | 25 | $166 | $7 |
| Simvastatin | 17 | $154 | $9 |
| Zolpidem | 32 | $140 | $4 |
| Amoxicillin-Clavulanate Potass | 15 | $129 | $9 |
| Glipizide | 11 | $120 | $11 |
| Cyclobenzaprine | 12 | $101 | $8 |
| Donepezil | 11 | $94 | $9 |
| Hydrochlorothiazide | 13 | $93 | $7 |
| Alendronate | 18 | $83 | $5 |
| Ondansetron | 13 | $68 | $5 |
| Furosemide | 11 | $59 | $5 |
| Fluticasone Propionate | 14 | $59 | $4 |
| Clonazepam | 16 | $52 | $3 |
| Metoprolol | 12 | $36 | $3 |
| Glimepiride | 11 | $19 | $2 |
Year by year
| 2024 | 1,534 | 333 | 3% (49) | None | $137,653 |
| 2023 | 470 | 193 | 3% (14) | 10% | $38,452 |
| 2022 | 307 | 101 | None | None | $18,640 |
| 2021 | 314 | 110 | 5% (15) | 5% | $16,271 |
| 2020 | 193 | 104 | 11% (21) | 13% | $10,129 |
| 2019 | 392 | 183 | 4% (17) | None | $18,769 |
| 2018 | 162 | 45 | 0% (0) | None | $17,819 |
| 2017 | 96 | 23 | 0% (0) | None | $7,051 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Omeprazole | 15 | $676 | $45 |
| Atorvastatin | 26 | $623 | $24 |
| Metformin | 15 | $302 | $20 |
| Albuterol Sulfate Hfa | 12 | $299 | $25 |
| Amlodipine Besylate | 24 | $274 | $11 |
| Paxlovid (Eua) | 21 | $217 | $10 |
2022: 3 drugs
| Januvia | 11 | $6,794 | $618 |
| Atorvastatin | 19 | $440 | $23 |
| Metformin | 12 | $111 | $9 |
2021: 3 drugs
| Atorvastatin | 28 | $728 | $26 |
| Cephalexin | 17 | $141 | $8 |
| Lisinopril | 13 | $98 | $8 |
2020: 2 drugs
| Fluticasone Propionate | 12 | $252 | $21 |
| Hydrocodone-Acetaminophen | 11 | $132 | $12 |
2019: 5 drugs
| Atorvastatin | 25 | $351 | $14 |
| Doxycycline Hyclate | 12 | $210 | $17 |
| Fluticasone Propionate | 14 | $204 | $15 |
| Azithromycin | 23 | $134 | $6 |
| Cephalexin | 12 | $52 | $4 |
2018: 1 drug
| Atorvastatin | 15 | $270 | $18 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1922451772
- Licence
- CA NP95006451, NY 686900
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Federal specialty code 163W00000X (163W00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2016-07-18
- NPI last updated
- 2020-06-23
- NPI record certified
- 2020-06-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 751 Lombardi Ct, Santa Rosa, CA, 95407